Search

everythinglearnresearchcommunity

for

Search:↓

Injecting CD34+ cell-containing platelet-rich plasma can improve pattern hair loss more than placental extract treatment.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

PPAR activation can improve diabetic wound healing by enhancing blood vessel function.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

The saw palmetto extract effectively inhibits an enzyme linked to prostate issues, showing promise for prostate health.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

Platelet-rich plasma helps protect and improve ovarian function in rats treated with cyclophosphamide.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

5AR inhibitors like finasteride and dutasteride improve hair growth and slow hair loss in male pattern baldness.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

PRGF can improve acne and scars.

Platelet-rich plasma therapy is seen as a promising tissue repair method but lacks standardized protocols.

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Alternating treatment with two drugs could help cells in a rapid aging disease.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Interferon therapy is a promising and safe treatment for hepatitis B in Southeast Asia.